XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 31 filers reported holding XENON PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $402,000 | -21.2% | 127,563 | 0.0% | 0.05% | -11.1% |
| Q1 2017 | $510,000 | -48.1% | 127,563 | 0.0% | 0.05% | -42.6% |
| Q4 2016 | $982,000 | -4.9% | 127,563 | 0.0% | 0.09% | +2.2% |
| Q3 2016 | $1,033,000 | +37.2% | 127,563 | 0.0% | 0.09% | +16.5% |
| Q2 2016 | $753,000 | -15.6% | 127,563 | 0.0% | 0.08% | -19.4% |
| Q1 2016 | $892,000 | -13.1% | 127,563 | 0.0% | 0.10% | -1.0% |
| Q4 2015 | $1,026,000 | -2.7% | 127,563 | 0.0% | 0.10% | -9.2% |
| Q3 2015 | $1,054,000 | -28.3% | 127,563 | 0.0% | 0.11% | +2.8% |
| Q2 2015 | $1,471,000 | -31.6% | 127,563 | 0.0% | 0.11% | -42.1% |
| Q1 2015 | $2,151,000 | -14.6% | 127,563 | 0.0% | 0.18% | -10.3% |
| Q4 2014 | $2,519,000 | – | 127,563 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 850,000 | $15,215,000 | 3.58% |
| ACUTA CAPITAL PARTNERS, LLC | 412,500 | $7,384,000 | 2.66% |
| BVF INC/IL | 3,481,778 | $62,324,000 | 2.34% |
| Soleus Capital Management, L.P. | 708,117 | $12,675,000 | 2.28% |
| COMMODORE CAPITAL LP | 301,392 | $5,395,000 | 2.15% |
| DAFNA Capital Management LLC | 406,535 | $7,277,000 | 1.73% |
| Parkman Healthcare Partners LLC | 374,395 | $6,702,000 | 1.56% |
| Avoro Capital Advisors LLC | 3,650,000 | $65,335,000 | 1.13% |
| KNOTT DAVID M | 144,101 | $2,579,000 | 1.10% |
| Orbimed Advisors | 2,497,917 | $44,713,000 | 0.42% |